AstraZeneca and Cephalon
Outcome
OIG enforcement action against AstraZeneca and Cephalon for healthcare fraud. Penalty: $46.5 million.
Details
AstraZeneca and Cephalon — OIG Enforcement (2026)
OIG took enforcement action against AstraZeneca and Cephalon in 2026 involving healthcare fraud violations in the Healthcare General sector.
Penalty: $46.5 million
Violation types: Healthcare Fraud
Entity type: Healthcare Provider
Penalty type: Settlement
Source: AstraZeneca and Cephalon to Pay $46.5 Million and $7.5 Million, Respectively, for Allegedly Underpaying Rebates Owed Under Medicaid Drug Rebate Program
How Crucible Prevents This
Crucible's compliance monitoring controls for Healthcare / General would have detected the patterns underlying this violation through automated screening, documentation enforcement, and real-time alert escalation.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works